SECOND NEOPLASMS IN DIAGNOSTIC PATIENTS OF POLYCYTHEMIA VERA (PV) OR MIELOFIBROSIS (MF) TREATED WITH RUXOLITINIB

被引：0

作者：

Sagues Serrano, M. ^{[1
]}

Osca Gelis, G. ^{[2
]}

Lopez Brunso, M. ^{[3
]}

Gonzalez Montes, Y. ^{[1
]}

Buch Villa, J. ^{[1
]}

Diaz Santa, J. ^{[1
]}

Coll Jorda, R. ^{[1
]}

Cruz Garcia, D. ^{[1
]}

Carvajal Nazly, Santos Y. ^{[1
]}

Lloveras Guelque, N. ^{[1
]}

Kelleher, N. ^{[1
]}

Roncero Vidal, J. M. ^{[1
]}

Blanco Blanco, A. B. ^{[1
]}

Mostacedo Marasovic, S. Z. ^{[1
]}

Bustins Tarrats, A. ^{[1
]}

Serrando Querol, M. ^{[4
]}

Jimenez Romero, O. ^{[4
]}

Tuset Andujar, E. ^{[1
]}

Gallardo Giralt, D. ^{[1
]}

机构：

[1] Hosp Univ Girona Dr Josep Trueta, Serv Hematol, ICO Girona, Girona, Spain

[2] Univ Girona, Fac Ciencies Econ & Empresarials, Hosp Univ Girona Dr Josep Trueta, ICO Girona, Girona, Spain

[3] Hosp Univ Girona Dr Josep Trueta, Serv Farm Hosp, ICO Girona, Girona, Spain

[4] Inst Catala Salut, Lab Clin Area Terr Girona, Girona, Spain

来源：

HAEMATOLOGICA | 2019年 / 104卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PO-196

引用

页码：310 / 311

页数：2

共 50 条

[21] OUTCOMES OF 121 PREGNANCIES IN PATIENTS WITH POLYCYTHEMIA VERA (PV)
Griesshammer, M.
Andreoli, A.
Schauer, S.
Gotic, M.
Barbui, T.
Doehner, K.
Kiladjian, J. J.
HAEMATOLOGICA, 2016, 101 : 6 - 6
[22] Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantation
Dold, Leona
Lutz, Philipp
Heine, Annkristin
Weismuller, Tobias J.
Strassburg, Christian P.
Spengler, Ulrich
CLINICAL CASE REPORTS, 2021, 9 (09):
[23] Combination Therapy with Ruxolitinib and Interferon in Newly Diagnosed Patients with Polycythemia Vera
Sorensen, Anders Lindholm Lindholm
Skov, Vibe
Kjaer, Lasse
Eickhardt-Dalboge, Christina Schjellerup Schjellerup
Larsen, Morten Kranker
Nielsen, Claus
Thomsen, Carsten
Gjerdrum, Lise Mette Rahbek
Knudsen, Trine Alma
Ellervik, Christina
Overgaard, Ulrik Malthe
Andersen, Christen Lykkegaard
Bjorn, Mads Emil
Hasselbalch, Hans Carl
BLOOD, 2022, 140 : 6806 - 6807
[24] Epidemiology of Myelofibrosis (MF), Polycythemia Vera (PV) and Essential Thrombocythemia (ET) in the European Union (EU)
Moulard, Odile
Mehta, Jyotsna
Olivares, Robert
Iqbal, Usman
Mesa, Ruben A.
BLOOD, 2012, 120 (21)
[25] Treatment of the blood cancer polycythemia vera with ruxolitinib in the MAJIC-PV study: a plain language summary
Harrison, Claire N.
Fox, Sonia
Boucher, Rebecca
McMullin, Mary Frances
Mead, Adam J.
FUTURE ONCOLOGY, 2024, 20 (40) : 3365 - 3376
[26] Normal life expectancy for polycythemia vera (PV) patients is possible
Abu-Zeinah, Ghaith
Silver, Richard T.
Abu-Zeinah, Khalid
Scandura, Joseph M.
LEUKEMIA, 2022, 36 (02) : 569 - 572
[27] Normal life expectancy for polycythemia vera (PV) patients is possible
Ghaith Abu-Zeinah
Richard T. Silver
Khalid Abu-Zeinah
Joseph M. Scandura
Leukemia, 2022, 36 : 569 - 572
[28] Imatinib mesylate therapy for patients (pts) with polycythemia vera (PV)
Borthakur, G
Kantarjian, H
Verstovsek, S
O'Brien, S
Giles, F
Koller, C
Rios, MB
Cortes, JE
BLOOD, 2004, 104 (11) : 428A - 428A
[29] Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study
Theocharides, Alexandre
Gisslinger, Heinz
De Stefano, Valerio
Accurso, Vincenzo
Iurlo, Alessandra
Devos, Timothy
Egyed, Miklos
Lippert, Eric
Delgado, Regina Garcia
Cantoni, Nathan
Dahm, Anders E. A.
Sotiropoulos, Damianos
Houtsma, Erik
Smyth, Aoife
Iqbal, Amir
Di Matteo, Paola
Zuurman, Mike
te Boekhorst, Peter A. W.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (03) : 379 - 391
[30] Ruxolitinib Efficacy By Hematocrit Control in Patients with Polycythemia Vera: An Analysis of the RESPONSE Trial
Verstovsek, Srdan
Kiladjian, Jean-Jacques
Mesa, Ruben
Jones, Mark M.
He, Shui
Li, Jingjin
Habr, Dany
Vannucchi, Alessandro M.
BLOOD, 2014, 124 (21)

← 1 2 3 4 5 →